Brief: Pediapharm acquires the U.S. rights to naproxen suspension

Medexus Pharmaceuticals

09/03/2015 12:00

March 9 (Reuters) - Pediapharm Inc  PDP.V : 
 * Acquires United States rights to naproxen suspension 
 * Says intends to make the Pediapharm naproxen suspension available again in 
   United States before the end of 2016 
 * Says has entered into an asset purchase agreement regarding the US rights to 
   roche's naproxen oral suspension 
 * Says Roche will retain the Naprosyn(TM) trademark and retains all product 
   rights to the other oral dosage forms under this brand 
 
 * Source text for Eikon  ID:nCCN84C4rS  
 
 * Further company coverage  PDP.V   
 
 ((Bengaluru Newsroom; +1 646 223 8780))